The fourth “Asia Summit on Global Health,” hosted by the Hong Kong Trade Development Council, was recently concluded with resounding success. A highlight of the event was Dr. Tom Du's expert analysis of Hong Kong's future biomedical industry. As the Chairman of Evergreen Therapeutics and a former senior FDA reviewer, Dr. Tom Du, offered valuable perspectives during the summit's expert roundtable session.

The letter from the CEO of the Hong Kong Trade Development Council

This forum garnered significant attention from the Special Administrative Region Government, with notable leaders in attendance, including Chief Executive of the Hong Kong Special Administrative Region John Lee, Deputy Director of the National Health Commission Cao Xuegang, Chairman of the Hong Kong Trade Development Council Lin Zhenyu, and Director of the Department of Health of the Hong Kong Special Administrative Region Luo Chongmao. The conference also welcomed over 80 international scientific and medical experts, business leaders, and investors from the global medical and health industry, such as 2006 Nobel Prize Laureate in Chemistry, Professor Roger Kornberg.